THE PREDICTABLE VALUE OF ANTICONVULSANT INDICES

[1] ABDULIAN DH, 1955, J PHARMACOL EXP THER, V113, P439

[2] CHEN G, 1951, J PHARMACOL EXP THER, V103, P54

[3] GIBBS FA, TEACHING CHART MODIF

[4] JENNEY EH, 1954, FED PROC, V13, P370

[5] JENNEY EH, UNPUBLISHED

[6] KING EE, 1953, FED PROC, V12, P336

[7] FURTHER EVALUATION OF ACETAZOLAMIDE (DIAMOX) IN TREATMENT OF EPILEPSY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (04): : 268 - 272

[8] MILLICHAP JG, 1955, J PHARMACOL EXP THER, V115, P251

[9] ORLOFF MJ, 1951, NEUROLOGY, V1, P377, DOI 10.1212/WNL.1.9-10.377

[10] ORLOFF MJ, 1949, P SOC EXP BIOL MED, V70, P254

[1] ABDULIAN DH, 1955, J PHARMACOL EXP THER, V113, P439

[2] CHEN G, 1951, J PHARMACOL EXP THER, V103, P54

[3] GIBBS FA, TEACHING CHART MODIF

[4] JENNEY EH, 1954, FED PROC, V13, P370

[5] JENNEY EH, UNPUBLISHED

[6] KING EE, 1953, FED PROC, V12, P336

[7] FURTHER EVALUATION OF ACETAZOLAMIDE (DIAMOX) IN TREATMENT OF EPILEPSY [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (04): : 268 - 272

[8] MILLICHAP JG, 1955, J PHARMACOL EXP THER, V115, P251

[9] ORLOFF MJ, 1951, NEUROLOGY, V1, P377, DOI 10.1212/WNL.1.9-10.377

[10] ORLOFF MJ, 1949, P SOC EXP BIOL MED, V70, P254